MiMedx Group Quarterly Cash Flow Statement
NASDAQ: MDXGHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
MiMedx Group free cash flow
In the quarter ended Jun 30, 2026, MiMedx Group generated -$10.0 million of operating cash flow. That left free cash flow of -$10.0 million, a free-cash-flow margin of -15.6% of revenue. Free cash flow was down 169.5% from the prior year's $14.4 million.
Summary generated from market data by MetaCap's automated system. Methodology
MiMedx Group cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -14.84M | -10.86M | 15.19M | 16.75M | 9.62M | 7.02M | 7.44M | 8.10M | 17.63M | 9.26M | 53.48M | 8.53M |
| Net Income growth (YoY) | -254.29% | -254.63% | +104.24% | +106.89% | -45.43% | -24.17% | -86.09% | -5.14% | +1368.75% | — | — | — |
| Depreciation & Amortization | 441.00K | 528.00K | 572.00K | 572.00K | 558.00K | 558.00K | 564.00K | 580.00K | 558.00K | 558.00K | 611.00K | 653.00K |
| Stock-Based Compensation | 903.00K | -1.70M | 2.46M | 4.92M | 4.75M | 4.26M | 4.69M | 3.81M | 4.09M | 4.34M | 4.39M | 4.39M |
| Change in Working Capital | 971.00K | 31.52M | -2.96M | -13.42M | -11.08M | -6.88M | -494.00K | -119.00K | 270.00K | -7.20M | -6.69M | -1.95M |
| Operating Cash Flow | -10.02M | 1.88M | 24.96M | 29.33M | 14.42M | 5.30M | 18.78M | 19.62M | 21.81M | 5.98M | 10.26M | 12.79M |
| Capital Expenditures | — | — | — | — | — | — | — | — | — | — | -427.00K | -628.00K |
| Investing Cash Flow | -635.00K | -5.64M | -335.00K | -5.26M | -887.00K | -406.00K | -2.77M | 113.00K | -905.00K | -6.02M | -481.00K | -649.00K |
| Financing Cash Flow | -13.28M | -2.58M | -583.00K | -857.00K | -1.09M | -2.88M | -400.00K | 27.00K | -359.00K | -33.47M | -8.94M | 370.00K |
| Net Change in Cash | -23.93M | -6.35M | 24.04M | 23.21M | 12.44M | 2.02M | 15.62M | 19.76M | 20.55M | -33.51M | 836.00K | 12.51M |
| Free Cash Flow | -10.02M | 1.88M | 24.96M | 29.33M | 14.42M | 5.30M | 18.78M | 19.62M | 21.81M | 5.98M | 9.83M | 12.16M |
This table shows 12 quarterly periods of MiMedx Group's cash flow statement, from Q2 2026 back to Q3 2023, across 11 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow MDXG's reporting calendar. What is a cash flow statement?